BrightAccountsProduction v1.0.0 v1.0.0 2024-10-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company during the year was that of wholesale of pharmaceutical goods and other business support service activities. 26 June 2026 0 0 09774806 2025-09-30 09774806 2024-09-30 09774806 2023-09-30 09774806 2024-10-01 2025-09-30 09774806 2023-10-01 2024-09-30 09774806 uk-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 09774806 uk-curr:PoundSterling 2024-10-01 2025-09-30 09774806 uk-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 09774806 uk-bus:FullAccounts 2024-10-01 2025-09-30 09774806 uk-core:ShareCapital 2025-09-30 09774806 uk-core:ShareCapital 2024-09-30 09774806 uk-core:RetainedEarningsAccumulatedLosses 2025-09-30 09774806 uk-core:RetainedEarningsAccumulatedLosses 2024-09-30 09774806 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-09-30 09774806 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-09-30 09774806 uk-bus:FRS102 2024-10-01 2025-09-30 09774806 uk-core:WithinOneYear 2025-09-30 09774806 uk-core:WithinOneYear 2024-09-30 09774806 2024-10-01 2025-09-30 09774806 uk-bus:Director1 2024-10-01 2025-09-30 09774806 uk-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: 09774806
 
 
Transcom Ltd
 
Unaudited Financial Statements
 
for the financial year ended 30 September 2025
Transcom Ltd
Company Registration Number: 09774806
BALANCE SHEET
as at 30 September 2025

2025 2024
Notes £ £
 
Current Assets
Debtors 4 54,686 54,686
Cash and cash equivalents 100 100
───────── ─────────
54,786 54,786
───────── ─────────
Creditors: amounts falling due within one year 5 (91,540) (91,540)
───────── ─────────
Net Current Liabilities (36,754) (36,754)
───────── ─────────
Total Assets less Current Liabilities (36,754) (36,754)
═════════ ═════════
 
Capital and Reserves
Called up share capital 100 100
Retained earnings (36,854) (36,854)
───────── ─────────
Equity attributable to owners of the company (36,754) (36,754)
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account and Director's Report.
           
For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 26 June 2026
           
           
________________________________          
Mr Komiljon Khodjaev          
Director          
           



Transcom Ltd
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 30 September 2025

   
1. General Information
 
Transcom Ltd is a company limited by shares incorporated and registered in England. The registered number of the company is 09774806. The registered office of the company is 167-169 Great Portland Street, London, W1W 5PF, England which is also the principal place of business of the company. The principal activity of the company during the year was that of wholesale of pharmaceutical goods and other business support service activities. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 30 September 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.

 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
Financial Instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, the with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
 
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not discounted.
 
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
 
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 0, (2024 - 0).
       
4. Debtors 2025 2024
  £ £
 
Trade debtors 54,686 54,686
  ═════════ ═════════
       
5. Creditors 2025 2024
Amounts falling due within one year £ £
 
Trade creditors 75,325 75,325
Other creditors 16,215 16,215
  ───────── ─────────
  91,540 91,540
  ═════════ ═════════
       
6. Capital commitments
 
The company had no material capital commitments at the financial year-ended 30 September 2025.
   
7. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.